Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.52 |
| ▸ | ANPEP | P15144 | 3/20 | 0.47 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.47 |
| ▸ | DNPEP | Q9ULA0 | 2/20 | 0.47 |
| ▸ | LARS1 | Q9P2J5 | 3/20 | 0.44 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | RRM1 | P23921 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11078078 | 1.00 | SLC7A5 (0.52) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL7381920 | 0.85 | CAPN1 (0.46) | SLC7A5ANPEPRNPEPDNPEPMAPT | |
| SCHEMBL13789959 | 0.84 | SLC7A5 (0.54) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL6507884 | 0.83 | DPP7 (0.50) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL8768451 | 0.83 | SLC7A5 (0.52) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| Hydrochloric Acid SCHEMBL8624056 | 0.83 | SLC7A5 (0.52) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| Hydrochloric Acid SCHEMBL8624053 | 0.83 | SLC7A5 (0.52) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL25328112 | 0.81 | SLC7A5 (0.50) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL9113004 | 0.81 | DPP7 (0.52) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL830163 | 0.80 | SLC7A5 (0.45) | SLC7A5ANPEPRNPEPDNPEPLARS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220025370-A1 | OLIGOMER-CONJUGATE COMPLEXES AND THEIR USE | IONIS PHARMACEUTICALS, INC. (US) | 2022-01-27 | — | — | US | disclosed |
| US-20170066787-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. | 2017-03-09 | — | — | US | disclosed |
| US-9572823-B2 | Boron-containing small molecules | ANACOR PHARMACEUTICALS, INC. (US) | 2017-02-21 | — | — | US | disclosed |
| US-20110263539-A1 | SHIP 1 MODULATOR COMPOUNDS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2011-10-27 | — | — | US | disclosed |
| US-20100323990-A1 | SHIP 1 MODULATOR PRODRUGS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2010-12-23 | — | — | US | disclosed |
| US-4483988-A | Substituted derivatives of 4-t-alkoxycarbonyl-piperazin-2-ones | RICHARDSON MERRELL INC. (US) | 1984-11-20 | — | — | US | disclosed |
| US-4435571-A | 5-(Substituted benzyl)-6-oxo-2-piperazine carboxylic acids and esters | RICHARDSON MERRELL INC. (US) | 1984-03-06 | — | — | US | disclosed |
| US-4341698-A | Enkaphalin derivatives | RICHARDSON-MERRELL INC. (US) | 1982-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100323990-A1 | SHIP 1 MODULATOR PRODRUGS | PPM1D, PPM1G, PPM1F | SLC7A5 3768/4885ANPEP 4534/4885RNPEP 4693/4885 |
| US-20170066787-A1 | BORON-CONTAINING SMALL MOLECULES | ETF1, POLR1C, DPM1 | SLC7A5 45/4885ANPEP 1265/4885RNPEP 1011/4885 |
| US-20220025370-A1 | OLIGOMER-CONJUGATE COMPLEXES AND THEIR USE | DCLRE1B, NT5C3B, PAICS | SLC7A5 2328/4885ANPEP 943/4885RNPEP 603/4885 |
| US-20110263539-A1 | SHIP 1 MODULATOR COMPOUNDS | PPM1F, PPM1D, PPP1R1B | SLC7A5 4451/4885ANPEP 4748/4885RNPEP 4689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.